fda 101
Published 9 years ago • 967 plays • Length 51:33Download video MP4
Download video MP3
Similar videos
-
1:11:57
dm drug development & approval considerations with the fda - 2023 mdf annual conference
-
55:14
dm 101: overview of dm
-
54:33
dyne therapeutics - meet the dm drug developers
-
1:13:33
dyne therapeutics (july) - meet the dm drug developers 2024
-
55:09
dyne therapeutics - meet the dm drug developers
-
53:07
dyne therapeutics demonstrating force™ platform delivery to cns - 2023 meet the dm drug developers
-
57:30
#letstalknmd - myotonic dystrophy 101
-
42:13
u.s. drug testing & approval process (2013 mdf annual conference)
-
55:44
industry updates: day 2 - 2023 mdf annual conference
-
47:00
dyne therapeutics - meet the dm drug developers 2023
-
1:13
los angeles, california highlights - 2024 myotonic dystrophy foundation regional conference
-
1:12:06
clinical trial readiness workshop - 2021 mdf annual conference
-
1:31
gainesville, florida highlights - 2024 myotonic dystrophy foundation regional conference
-
1:36:30
ask-the-expert: myotonic dystrophy & anxiety
-
1:01:48
amo pharma - meet the dm drug developers
-
51:37
myotonic dystrophy type 1: disease development & symptom management - 2023 mdf annual conference
-
1:13:08
understanding dm1 - 2022 mdf annual conference
-
1:12:45
industry updates part 1 - 2022 mdf annual conference